Management of anaemia in primary care
Shek-ying Lin 連錫營
HK Pract 2021;43:51-57
Summary
Anaemia is a very common problem in primary
care and also a serious global public health issue that
affects young children and pregnant women. In 2008,
WHO estimated that 42% of children under 5 years old
and 40% of pregnant women were anaemic and the
issue was more severe in the developing world.1
While anaemia of chronic disease is more
common in elderly with multiple co-morbidities, iron
deficiency in this age group can indicate possible
gastrointestinal or gynaecological malignancy.
Anaemia is only a presenting symptom with a wide
range of underlying causes or conditions, from the
common uterine fibroid (UF) to the rare pure red cell
aplasia (PRCA) secondary to parvovirus infection.
A practical yet comprehensive approach is very
important to avoid unnecessary investigation but not
missing sinister or readily treatable diagnoses. In this
article, the common causes and initial approach to
anaemia are reviewed. First line investigations, their
interpretation and subsequent work-up in primary care
settings are discussed.
Special attention is given to iron deficiency
anaemia and anaemia of chronic disease and tests
to differentiate these two commonest causes, or
conditions, presenting with anaemia, updated.
摘要
貧血是基層醫療中非常常見的問題,也是影響幼兒
和孕婦的嚴重的全球性公共衛生問題之一。世衛組織估
計,4 2 %的5歲以下兒童和4 0 %的孕婦患有貧血,這一問
題在發展中國家更為嚴重。1雖然慢性病貧血在患有多種
疾病的老年人中較為常見,但這一年齡段的人缺鐵或許
預示著罹患胃腸道或婦科惡性腫瘤的可能。貧血只是一
種症狀表現,其潛在的病因很廣泛,從常見的子宮肌瘤
到罕見的繼發於細小病毒感染的單純紅細胞再生障礙性
貧血均包括在內。採用實用而全面的方法非常重要的,
可以避免不必要的調查,同時又不會漏診兇險或容易治
療的疾病。本文回顧了貧血的常見原因和初步治療方
法,討論了基層醫療機構的一線檢查、檢查結果解讀和
後續工作,尤其關注了缺鐵性貧血和慢性病性貧血,並
介紹了鑒別這兩種最常見原因的最新檢測方法。
Introduction
Anaemia is a condition in which the number of red
blood cells or the haemoglobin concentration is lower
than normal. The normal haemoglobin concentration
varies with age, diet, altitude of residence, smoking,
sex, pregnancy and menstruation. The most common
causes of, or conditions presenting with anaemia include
nutritional deficiencies, particularly iron deficiency
anaemia (IDA) and anaemia of chronic disease (ACD)
and IDA/ACD frequently coexisted.2
According to World Health Organisation (WHO)
criteria, anaemia is defined as a haemoglobin of
<13g/dL in men and 12g/dL in women3
though local
variations in haemoglobin distribution should be
considered.
Normal range of haemoglobin used in our Hospital
Authority is 11.5-15.4g/dL for women and 13.5-17.3g/dL
for men.
In Southern Chinese where thalassaemia is common,
we usually take a lower limit of normal at 11.5g/dL
for women according to our local reference range.
Classification of anaemias
Anaemia is commonly classified into three main
categories according to the mean corpuscular volume
(MCV), namely: macrocytic, normocytic and microcytic
anaemia. Table 1 shows a list of the common causes of
anaemia, or conditions, according to their MCV.
The in-out approach for classification of anaemia
considers red cells as a product and the quantity
of haemoglobin will then be a function of the raw
materials (nutrition supply), production plant (the bone
marrow) and consumption (destruction). Different
causes are listed in Table 2.
An approach to anaemia
The diagnostic approach to anaemia in primary
care should start with history and physical examination.
Afterwards there should be some baseline tests followed
by more specific investigations as indicated. A stepwise
approach is discussed below.
Taking a history
The severity of symptoms varies with the degree
of anaemia and most patients are asymptomatic unless
the haemoglobin falls below 10g/dL. Not infrequently
mild anaemia is detected during a health check, or a
blood test taken for other complaints. Symptoms of
anaemia include tiredness, fatigue, malaise, dyspnea on
exertion and decreased exercise tolerance. The severity
of symptoms depends on the rate of haemoglobin drop;
and patients with chronic kidney diseases commonly
tolerate anaemia despite a very low haemoglobin.
While anaemia from acute blood loss or haemolysis
are likely to have more severe symptoms. Symptoms
of angina or heart failure may indicate decompensation
and need urgent attention.
Dietary cause of iron deficiency is more frequent
in children, elderly and pregnancy. Folate deficiency is
more common in alcoholics and vitamin B12 deficiency
in vegetarian. Drug history of anti-convulsants,
cholestyramine, sulphasalazine or methotrexate is an
infrequent cause of folate deficiency. Chronic kidney
disease or other chronic inflammatory diseases are
top causes of anaemia of chronic illness. Past history
of gastrectomy or intestinal resection should alert the
possibility of B12 deficiency.
Physical examination
Physical signs may not be very obvious especially
if the patient presented early. Pallor, the diagnostic sign
for anaemia may be difficult to detect if haemoglobin is
more than 9g/dL. One study investigated the accuracy
of pallor at four different sites, namely tongue,
conjunctiva, palm and nail bed. The findings suggested
that at the haemoglobin cut-off point of 7g/dL, absence
of conjunctival pallor and tongue pallor completely
ruled out the probability of severe anaemia. However,
at haemoglobin cut-off points of 9g/dL, no particular
physical site resulted in sensitivity or specificity good
enough to rule in or rule out anaemia.4 Most patients
will become symptomatic when haemoglobin falls
below 7g/dL and urgent referral is warranted.
Jaundice may suggest haemolytic anaemia or
megaloblastic anaemia which has shortened red cell
survival or intramedullary haemolysis. Lymphadenopathy
will point to lymphoproliferative disease or other
malignancy. Ankle edema is a feature of heart failure
and severe anaemia which suggest decompensation.
Premature greying of hair often accompanies
megaloblastic anaemia and is associated with other
autoimmune diseases. Bleeding manifestations such as
petechiae, purpura, ecchymosis raise the possibility of
thrombocytopenia or marrow failure.
Classical signs of koilonychia in iron deficiency or
raw beef like glossitis in megaloblastic anaemia are now
rarely seen. Standard system examination is required
to detect evidence of chronic illness and especially
signs of occult malignancy. Hepatosplenomegaly
suggests myeloproliferative, lymphoproliferative disease
or haematological malignancies. Ataxia, peripheral
neuropathy, loss of vibration sense and proprioception
may be the presenting features of pernicious anaemia.
First-line investigations
A complete blood count (CBC), reticulocyte count
with differentials and blood smear is standard. Liver,
renal function, lactate dehydrogenase, iron, total iron
binding capacity, and ferritin are commonly requested
first line work up for anaemia. If chronic inflammatory
disease or infection is suspected, C-reactive protein can
be considered.
The CBC confirms the clinical suspicion of anaemia
and the red cell indices direct further investigation.
Local laboratory reference ranges that are age and
sex specific should be used. The reference ranges
for haemoglobin are affected by ethnicity, altitude,
nutritional factors and local prevalence of diseases
that can cause anaemia. Reticulocyte count gives an
indication of the bone marrow erythropoiesis activity,
especially its capacity to increase red cell production
in response to anaemia. A reticulocyte production index
(RPI) is a more accurate reflection of marrow activity
than an isolated reticulocyte count5
, because it corrects
for the degree of anaemia. A low absolute reticulocyte
count in an anaemic patient suggests marrow pathology
or anaemia of chronic illnesses.
Differential diagnoses are further classified by red
cell indices (Table 1) and hints for underlying causes
are frequently seen in peripheral blood smear (Table 3). Blood smears morphology of white cells is often the
first clue to the diagnosis of haematological malignancy,
however a well-trained technologist in haematology is
essential for the blood film interpretation.
Subsequent investigations
(1) Blood tests
For confirmed iron deficiency anaemia, underlying
chronic blood loss from gastrointestinal tract or
gynaecological origin must be vigorously sought
which often includes upper and lower endoscopy plus
gynaecology assessment. Isolated thalassaemia trait
seldom has a haemoglobin below 10g/dL and the
MCV is usually between 65-70 fL. Common alpha
or beta thalassaemia traits are usually identified by a
haemoglobin pattern while rarer haemoglobinopathies
may need molecular tests for the genetic defect.
Lead poisoning is rare unless there is occupational
exposure or environmental contamination. Normocytic
anaemia needs detailed system review to look for
underlying chronic illness, especially malignancy.
Mixed anaemia should always be considered if there
is a dimorphic blood picture with the concomitant
occurrence of microcytosis and macrocytosis despite
a normal MCV. In megaloblastic anaemia, we should
also check for antibodies against intrinsic factor
and parietal cell while upper endoscopy should be
considered for atrophic gastritis. Macrocytic anaemia is
rarely seen in hypothyroidism though thyroid function
test is usually part of the work up of macrocytosis.
Rouleaux formation in myeloma can occasionally
be misinterpreted as macrocytes by automated cell
counters. A high percentage of reticulocytes in
haemolytic anaemia will increase the MCV.
(2) Bone marrow biopsy
Bone Marrow (BM) examination is indicated when
first line investigations suggest an underproduction e.g.
a very low reticulocyte count or abnormal cells detected
in blood film. Sometimes when nutritional causes for
anaemia are excluded and no chronic disease can be
identified or the degree of anaemia is not proportional
to the degree of chronic disease, then a marrow biopsy
is required to exclude myelodysplasia, hypoplasia or
infiltration. Bone marrow aspirate allows morphological
assessment, cytochemistry and immuno-staining of
blood cells. Trephine biopsy permits better delineation
of cellularity and architecture of marrow. Pathology
such as granuloma, tumour infiltration and fibrosis
is more readily appreciated in trephine biopsy than
marrow aspirate. More specialized tests e.g. cytogenetic,
immunophenotyping or molecular test are required
in individuals suspected of having haematological
malignancy6
, therefore specialist opinion should be
sought before proceeding to marrow biopsy
Common types of anaemia
(1) Iron deficiency anaemia (IDA)
The total body iron store is around 3-4g in adults.
Most of the iron exists as haem in the haemoglobin.
One gram is stored in the liver, and a small amount is in
the muscle as myoglobin.7
About 20mg – 25mg of iron
is needed daily for production of red cells and cellular
metabolism and most of the iron in haem is recycled to
meet the demand. Men and non-menstruating women
lose about 1mg of body iron per day and menstruating
women lose an extra 1mg daily on average. Physiological
requirements increased rapidly during growth spurt,
menstruation, and pregnancy, and therefore iron
deficiency is more common in children and pregnancies.
Iron absorption from duodenum is upregulated by iron
deficiency and downregulated by infection or inflammation.
Dietary iron exists in two forms: haem iron and
non-haem iron. Fe2+ (ferrous iron) is more readily
absorbed than Fe3+ (ferric form). Animal food sources,
such as meat, poultry, and seafood contain iron in the
haem form, therefore is more readily absorbed than its
vegetarian counterpart.8
Serum iron measures the amount of iron bound to
transferrin in the plasma. Only a small amount of iron
is transferrin bound and there is a large fluctuation
of serum iron with dietary intake. The day to day
variations are so large that the serum iron results can
be misleading and must be interpreted together with the
iron binding capacity and ferritin.
The total iron-binding capacity (TIBC) determines
the amount of iron that can be bound to unsaturated
transferrin, i.e. the total number of transferrin binding
sites per unit volume of plasma. Unlike serum iron,
TIBC or total transferrin sites available do not change
rapidly with diet. TIBC will increase in response to
anaemia, however, its values do not change until iron
stores are depleted. TIBC and transferrin rise in iron
loss and fall in chronic disease.
Transferrin saturation is calculated by dividing
serum iron by TIBC. It is the percentage of transferrin
bound to iron. In iron deficiency, the amount of iron
is reduced and the TIBC will increase and therefore
the transferrin saturation will be reduced. A transferrin
saturation of < 15% together with an elevated TIBC
is indicative of iron deficiency anaemia. In anaemia
of chronic disease, both serum iron and TIBC will
decrease but the fluctuation of serum iron can be so
large that the 15% cutoff may become misleading.
Ferritin is the main iron storage protein in the
body, the majority of ferritin is intracellular and the
soluble form can be measured in the plasma. Ferritin
concentrations vary by age and gender because of
menstruation loss. A ferritin concentration of < 15 ng/ml
in adults is diagnostic of iron deficiency.9
However,
ferritin is an acute phase protein, so it may increase
in infection and inflammation. Therefore, a normal
ferritin concentration alone does not necessarily exclude
iron deficiency. A higher ferritin level of 100 ng/ml is
commonly accepted to indicate adequate iron.
(2) Anaemia of chronic disease (ACD)
Anaemia of chronic disease is a diagnosis of
exclusion e.g. in rheumatoid arthritis, anaemia can
be caused by iron deficiency after non-steroidal antiinflammatory drug, myelodysplasia due to methotrexate
or tuberculosis secondary to the use of biologics. And
the list of ACD is ever increasing. Some of the common
ones are listed in Table 4.
The pathogenesis of ACD involves ineffective
utilization of body iron, reduction in erythropoiesis,
and diminished response to erythropoietin stimulation.
Though not completely understood, the pathogenesis
is thought to be mediated through the actions of
tumour necrosis factor, interleukins (IL)-1 and -6 and
hepcidin.10 These cytokines and hepcidin, are believed
to inhibit iron release from the marrow macrophages
to the erythroid precursor cells. The management
of ACD is to investigate for the underlying chronic
disease and treat accordingly. However, ACD often has
overlapping iron profiles with IDA and sometimes both
conditions exist concurrently. It is important to identify
iron deficiency in this scenario as gastrointestinal or
gynaecological malignancy may be missed without
searching for the underlying cause for iron deficiency.11
Differentiate iron deficiency anaemia (IDA) and
anaemia of chronic disease (ACD)
Soluble transferrin receptor index
The transferrin receptor is a transmembrane cellular
protein expressed in cells that utilize iron, and the
soluble form is a fragment of the transferrin receptor
whose serum level rises in case of iron deficiency.
Soluble transferrin receptor (sTfR) has been shown to be
an accurate indicator of iron deficiency and is unaffected
by concomitant chronic disease and inflammation.
Patients with IDA or combined ACD/IDA have
significantly higher sTfR and sTfR Index values than
subjects with pure ACD. sTfR index is defined as sTfR
level divided by logarithm of ferritin concentration.
sTfR values > 1. 55 mg / Land sTfR Index values
>1.03mg/L were predictive of iron deficiency anemia
in the presence of inflammation or chronic disease.12
The combination of ferritin, sTfR and the sTfR Index
increases sensitivity to 92%. However, sTfR assay is
not available widely.
Reticulocyte haemoglobin
Reticulocytes are the youngest and the freshest red
cells released from the bone marrow into the blood and
they circulate for 1-2 days then become mature RBC.
The reticulocytes haemoglobin content reflects the
amount of iron available for haemoglobin production
in the bone marrow. Some automated cell counters
can generate this value from the cell volume and
haemoglobin concentration of the reticulocytes. A cut-off value of reticulocyte haemoglobin was determined
as 29.3 pg for female patients with IDA anemia (90.6%
sensitivity, 66.7% specificity).13
Haemolytic anaemia (HA)
For haemolytic anaemia, the typical laboratory
findings include: increased reticulocyte count,
unconjugated bilirubin, lactate dehydrogenase
and reduced haptoglobin. Blood film may show
polychromasia, agglutination and spherocytes. However,
not all abnormal laboratory parameters are present,
especially in mild and compensated haemolysis.
Urine dipstick can be positive for haemoglobin but
urine microscopy is negative for red cells if there is
intravascular haemolysis. Urine haemosiderin can be
detected in chronic intravascular haemolysis such as
paroxysmal nocturnal haemoglobinuria.
A positive direct antiglobulin test (DAT) indicates
the presence of immunoglobulin IgG or complement
(usually C3d) bound to the red cell membrane. Together
with the presence of haemolysis, a positive DAT
suggests an immune etiology but clinical assessment is
required before a diagnosis of AIHA is made because
false positive DAT can happen in healthy subjects,
hospitalised patients or after blood transfusion.14 The
further differentiation of different types of immune
haemolysis is beyond the scope of this article.
Mixed anaemia
Both iron deficiency anaemia and thalassaemia
are common in Hong Kong and have a low MCV.
Megaloblastic anaemia (MA) can be masked by
concomitant microcytic anaemia. Delayed diagnosis
of vitamin B12 deficiency can result in permanent
neurological deficits or memory loss. Therefore,
mixed types of anaemia should always be considered.
According to a local study, among 272 adult Chinese
patients diagnosed to have megaloblastic anaemia
caused by vitamin B12 deficiency, 20 or 7.35% of
patients (14 definite pernicious anaemia, four probables,
two postgastrectomy) had normal or low MCV.15 In the
study, all 20 patients had a low reticulocyte index and
a widened red cell distribution width (RDW) indicated
a maturation disorder. Serum bilirubin and lactate
dehydrogenase level reflect red cell turnover rate and
are elevated in ineffective erythropoiesis such as in
megaloblastic anaemia and thalassaemia. Another telltale sign is the dimorphic blood film which showed the
simultaneous occurrence of microcytic and macrocytic
cells in the same patient.
Treatment of IDA
Replacement of iron
A daily dose of 100mg to 200mg elemental iron
is recommended (e.g. 300mg bd of ferrous sulphate).
Different preparation of iron supplement has similar
efficacy and metallic taste and constipation are common
side effects which often limit its usage. Intravenous iron
such as ferric carboxymaltose or iron isomaltoside are
indicated in patients with poor tolerance or compliance
to oral replacement or there is an urgent need to raise
the haemoglobin level e.g. before surgery or acute blood
loss.16 Anaphylaxis to intravenous iron is infrequent
but it should be given in day care centers where
resuscitation facilities are available. Patients with
active infection, severe asthma, multiple drug allergies
or hyperparathyroidism should avoid intravenous iron
and specialist advice is required before iron infusion
in patients with rheumatoid arthritis or systemic lupus
erythematosus. Response to iron should be evident in 4
weeks. Search for underlying cause of iron deficiency
should not be delayed.
Conclusion
Anaemia is a diagnostic problem that is commonly
presented to the general practitioner. There are
numerous and varied differential diagnoses of anaemia.
Given the diversity of causes, a thorough history,
physical examination and systematic laboratory
investigation are the key elements towards making a
definitive diagnosis. The management should start with
a set of baseline investigations to narrow down the
list and followed by selected subsequent investigations
directed to the subtypes of anaemias. A systematic
approach is required to avoid over investigation while
not missing treatable causes especially malignancies.
Iron deficiency anaemia and anaemia of chronic disease
remain the most common causes of anaemia and further
study is required to differentiate them.
Shek-ying Lin, FHKAM (Medicine)
Consultant,
Haematology Division, Department of Medicine, United Christian Hospital, Hospital Authority
Correspondence to: Dr Shek-ying Lin, Haematology Division, Department of
Medicine, United Christian Hospital, 130 Hip Wo Street, Kwun
Tong, Kowloon, Hong Kong SAR.
E-mail: linsy@ha.org.hk
References:
-
de Benoist B, Mclean Erin, Egli Ines, et al. Worldwide prevalence of
anaemia 1993-2005. WHO Global Database on Anaemia, World Health
Organization. 2008.
-
Madua AJ, Ughasorob MD. Anaemia of chronic disease: an in-depth review.
Med Princ Pract. 2017;26:1-9.
-
WHO. Haemoglobin concentrations for the diagnosis of anaemia and
assessment of severity. Vitamin and Mineral Nutrition Information System.
Available from: https://www.who.int/vmnis/indicators/haemoglobin.pdf
-
Kalantri A, Karambelkar M, Joshi R, et al. Accuracy and reliability of pallor
for detecting anaemia: a hospital-based diagnostic accuracy study. PLoS One.
2010 Jan 1;5(1):e8545.
-
Secic D, Omerbasic A, Drljo M, et al. New simplified formula for RPIreticulocyte production index. HealthMED. 2011 Jan;5(6):1815-1820.
-
Celalettina U, Guidob M. Emerging diagnostic and therapeutic approaches
in core binding factor acute myeloid leukaemia. Current Opinion in
Hematology. 2015 Mar;22(2):85-91.
-
Pasricha SRS, Flecknoe-Brown SC, Allen KJ, et al. Diagnosis and
management of iron deficiency anaemia: a clinical update. Med J Aust. 2010
Nov 1;193(9):525-532.
-
Ems T, St Lucia K, Huecker MR. Biochemistry, iron absorption. In:
StatPearls. StatPearls Publishing. 2021 Jan.
-
Peng YY, Uprichard J. Ferritin and iron studies in anaemia and chronic
disease. Annals of Clinical Biochemistry. 2017;54(1):43-48.
-
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med.
2005;352:1011-1023.
-
Cullis JO. Diagnosis and management of anaemia of chronic disease: current
status. British Journal of Haematology. 2011;154:289-300.
-
Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis
of anemia of chronic disease and iron deficiency anemia: a prospective
multicenter evaluation of soluble transferrin receptor and the sTfR/log
ferritin index. Am. J. Hematol. 2011;86:923-927.
-
Karagulle M, Gündüz E, Mutlu FS, et al. Clinical significance of reticulocyte
haemoglobin content in the diagnosis of iron deficiency anemia. Turk J
Hematol. 2013;30:153-156.
-
Bicakcib Z, Öztürkmen S, Akyay A, et al. False positive result of the Direct
Antiglobulin Test (DAT): the role of the elevated level of immunoglobulin.
Pediatric Hematology and Oncology. 2012 June;29(7):611-619.
-
Chan CWJ, Liu SYH, Kho CSB, et al. Diagnostic clues to megaloblastic
anaemia without macrocytosis. In Jnl Lab Hem. 2007;29:163-171.
-
Mak LY, Lau CW, Hui YT, et al. Joint recommendations on management of
anaemia in patients with gastrointestinal bleeding in Hong Kong. Hong Kong
Med J. 2018;24:416-422.
|